PUNE, India, April 9, 2018 /PRNewswire/ -- According to a new market research report "Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 25.12 Billion by 2022 from USD 20.67 Billion in 2017, at a CAGR of 4.0% during the forecast period.
Browse 170 market data Tables and 31 Figures spread through 180 Pages and in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market"
https://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html
Ad Statistics
Times Displayed: 7262
Times Visited: 23 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Early buyers will receive 10% customization on this report
Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market.
The hospitals segment accounted for the largest share of the Cardiac Monitoring and Cardiac Rhythm Management Devices Market in 2017
By end user, the Cardiac Monitoring and Cardiac Rhythm Management Devices Market is classified into hospitals, home & ambulatory care settings, and other end users. In 2017, the hospitals segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to the increasing use of these devices in hospitals, increasing burden of cardiovascular & coronary heart diseases, growing number of patient visits to physician offices for the principal diagnosis of CVD & CHD, and growing number of cardiac implant procedures.
The external defibrillators segment is expected to grow at the highest CAGR in defibrillators market during the forecast period
By type, the defibrillators market is divided into implantable and external defibrillators. The external defibrillators segment is expected to grow at the highest CAGR during the forecast period. This positive growth is attributed to the implementation of defibrillation programs in various countries and the launch of technologically advanced AED devices in the market
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=55
Asia is expected to grow at the highest CAGR during the forecast period
